Skip to main content
SpringerLink
Log in

Experimental systems for analysis of the malignant phenotype

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Identification of the cellular and subcellular alterations responsible for the metastatic behavior of malignant tumor cells and development of reliable screening programs for detecting new therapeutic agents for improved treatment of metastatic disease both depend crucially on the availability of experimental systems that can serve as relevant models of human cancer. Recent advances in our understanding of the pathogenesis of cancer metastasis have raised serious doubts about the usefulness of many of the experimental approaches that have long been used in the study of metastasis. Recent findings showing that metastases are caused by specific subpopulations of metastatic tumor cells, and that not all cells in a malignant primary tumor possess metastatic properties, are of profound importance for experimental efforts to understand the mechanism of metastasis and to develop effective therapies for metastatic disease. Heterogeneity in the expression of the metastatic phenotype among cells from the same tumor means that the traditional, and widely used, approach of analyzing primary tumors and cultured cell lines containing multiple, phenotypically heterogeneous, subpopulations of cells may provide little or no insight into the properties of the metastatic subpopulations, particularly if they represent only a minor fraction of the entire population. Similarly, the practice of screening potential therapeutic modalities for their ability to reduce the mass and/or growth rate of a primary tumor may be inadequate in predicting the responsiveness of metastatic lesions. Solution of these problems requires that new methods must be devised to isolate and characterize the specific subpopulations of tumor cells endowed with metastatic potential. In addition, knowledge of how the extraordinary phenotypic diversity found in tumor cell subpopulations from the same tumor is generated and how subpopulation diversity is regulated during progressive growth of both the primary tumor and its metastases are of fundamental importance if we are to design meaningful experimental systems for studying the metastatic process. This article reviews our current understanding of these complex issues and their implications for the experimental analysis of the malignant phenotype. The merits and shortcomings of different experimental systems are discussed in detail together with the identification of areas in which new experimental strategies and models are now needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sanford, KK: Biologic manifestations of oncogenesis in vitro: a critique. J Natl Cancer Inst 53: 1481–1485, 1974.

    Google Scholar 

  2. Ossowski, L, Reich, E: Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters. Cancer Res 40: 2310–2315, 1980.

    Google Scholar 

  3. Poste, G, Fidler, IJ: The pathogenesis of cancer metastasis. Nature 283: 139–146, 1980.

    Google Scholar 

  4. Weiss, L: Metastasis: differences between cancer cells in primary and secondary tumors. Pathobiol Ann 10: 51–81, 1980.

    Google Scholar 

  5. Foulds, L: The histologic analysis of mammary tumors of mice. II. The histology of responsiveness and progression. The origins of tumors. J Natl Cancer Inst 17: 713–756, 1956.

    Google Scholar 

  6. Mintz, B, Fleishman, RA: Teratocarcinomas and other neoplasms as developmental defects in gene expression. Adv Cancer Res 34: 211–278, 1981.

    Google Scholar 

  7. McKinnell, RG, Diberardino, MA, Blumenfeld, B, Bergard, RD (eds): Differentiation and neoplasia. Springer Verlag, Berlin, 1980.

    Google Scholar 

  8. Nowell, PC: The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194: 23–28, 1976.

    Google Scholar 

  9. Fogh, J, Giovanella, BC (eds): The Nude mouse in experimental and clinical research. Academic Press, New York, 1978.

    Google Scholar 

  10. Hanna, N, Fidler, IJ: Expression of metastatic potential of allogenic and xenogenic neoplasms in young nude mice. Cancer Res 41: 438–444, 1981.

    Google Scholar 

  11. Hanna, N: Natural killer cells and metastasis. Cancer Metastasis Reviews 1: 45–64, 1982.

    Google Scholar 

  12. Hanna, N: Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer 26: 675–680, 1980.

    Google Scholar 

  13. Hanna, N, Fidler, IJ: Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxicity in three murine tumor systems. J Natl Cancer Inst 66: 1183–1190, 1981.

    Google Scholar 

  14. Schabel, FMJr, Griswold, DPJr. Corbett, TH, Laster, WR, Lloyd, HH, Rose, WC: Variable responses of advanced solid tumors of mice to treatment with anticancer drugs. In: Fidler, IJ, White, RJ (eds). Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982, pp 95–113.

    Google Scholar 

  15. Steel, GG, Peckham, MJ: Human tumour xenografts: a critical appraisal. Br J Cancer 41: Suppl IV, 133–141, 1980.

    Google Scholar 

  16. Rockwell, S: In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. Br J Cancer 41: Suppl IV, 118–122, 1980.

    Google Scholar 

  17. Woodruff, MFA (ed): The interaction of cancer and host. Grune & Stratton, New York, 1980.

    Google Scholar 

  18. Hewitt, HB: The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res 27: 149–200, 1978.

    Google Scholar 

  19. Cotchin, E: Comparative oncology: the veterinary contribution. Proc Roy Soc Med 69: 649–656, 1976.

    Google Scholar 

  20. Jeglum, A: The use of spontaneous feline neoplasms for studies of therapeutic agents. In: Fidler, IJ, White, R (eds) Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982, pp 193–205.

    Google Scholar 

  21. Gillette, EL: Spontaneous canine neoplasms as models for therapeutic agents. In: Fidler, IJ, White, R (eds) Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982, pp 185–192.

    Google Scholar 

  22. Fidler, IJ, Gruys, E, Cifone, MA: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67: 947–956, 1981.

    Google Scholar 

  23. Reading, CL, Brunson, KW, Torriani, M, Nicolson, GL: Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA-tumor virus envelope glycoprotein gp70. Proc Natl Acad Sci USA 77: 5943–5947, 1980.

    Google Scholar 

  24. Fidler, IJ, Nicolson, GL: The immunobiology of experimental metastatic melanoma. Cancer Biol Rev 2: 1–47, 1981.

    Google Scholar 

  25. Shearman, PJ, Longenecker, BM: Clonal variation and functional correlation of organ-specific metastasis and an organ-specific metastasis-associated antigen. Int J Cancer 27: 387–395, 1981.

    Google Scholar 

  26. Kripke, M: Immune reactivity to autochthonous tumors in ultraviolet carcinogenesis. Cancer Biol Rev 1: 221–250, 1980.

    Google Scholar 

  27. Fidler, IJ: General considerations for studies of experimental cancer metastasis. Methods Cancer Res 15: 399–434, 1978.

    Google Scholar 

  28. Kyriazis, AA, Kyriazis, AP: Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation. Cancer Res 40: 4509–4511, 1980.

    Google Scholar 

  29. Morrissey, LW, Sidky, YA, Auerbach, R: Regional differences in the growth of tumor cells injected intraperitoneally into syngeneic acult mice. Cancer Res 40: 2197–2201, 1980.

    Google Scholar 

  30. Auerbach, R, Auerbach, W: Regional differences in the growth of normal and neoplastic cells. Science 215: 127–134, 1982.

    Google Scholar 

  31. Kripke, ML, Gruys, E, Fidler, IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 38: 2962–2967, 1978.

    Google Scholar 

  32. Stackpole, CW: Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature 289: 798–800, 1981.

    Google Scholar 

  33. Giavazzi, R, Alessandri, G, Spreafico, F, Garattini, S, Mantovani, A: Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer 42: 462–472, 1980.

    Google Scholar 

  34. Talmadge, JE, Key, M, Hart, IR: In vitro characterization of a transplantable murine reticulum cell sarcoma. Cancer Res 41: 1271–1280, 1981.

    Google Scholar 

  35. Tarin, D, Price, JE: Metastatic colonization potential of primary tumour cells in mice. Br J Cancer 39: 740–754, 1979.

    Google Scholar 

  36. Trope, C: Different susceptibilities of tumor cell subpopulations to cytotoxic agents. In: Fidler, IJ, White, R (eds) Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982, pp 64–79.

    Google Scholar 

  37. Fidler, IJ, Hart, IR: Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res 41: 3266–3267, 1981.

    Google Scholar 

  38. Henderson, JS, Rous, P: The plating of tumor components on the subcutaneous expanses of young mice. Findings with benign and malignant epidermal growths and with mammary carcinomas. J Exp Med 115: 1211–1230, 1962.

    Google Scholar 

  39. Prehn, RT: Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas. J Natl Cancer Inst 45: 1039–1045, 1970.

    Google Scholar 

  40. Pimm, MV, Baldwin, RW: Antigenic differences between primary methylcholanthrene-induced rat sarcomas and post-surgical recurrences. Int J Cancer 20: 37–49, 1977.

    Google Scholar 

  41. Hakanssan, L, Trope, C: On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. Acta Pathol Microbiol Scand 82: A, 35040, 1974.

    Google Scholar 

  42. Wallen, CA, Michaelson, SM, Wheeler, KT: Influence of location within a tumor on cell survival as measured by a clonogenic assay. Cancer Res 41: 989–993, 1981.

    Google Scholar 

  43. Pretlow, TGII, Pretlow, TP: Separation of individual kinds of cells from tumors. In: Wirtz, IP, Hanna, MGJr (eds) Contemporary topics in immunobiology, Vol 10. Plenum, New York, 1980, pp 21–60.

    Google Scholar 

  44. Russell, SW, Gillespie, GY, Pace, JL: Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities. In: Wirtz, IP, Hanna, MGJr (eds) Contemporary topics in immunobiology, Vol 10. Plenum, New York, 1980, pp 143–166.

    Google Scholar 

  45. Klein, E: Gradual transformation of solid into ascites tumors. Evidence favoring the mutation-selection theory. Exp Cell Res 8: 188–199, 1955.

    Google Scholar 

  46. Koch, FE: Für Frage der metastasenbildung bei impftumour. Krebforsch 28: 495–516, 1939.

    Google Scholar 

  47. Fidler, IJ: Selection of successive tumor lines for metastasis. Nature New Biol 242: 148–149, 1973.

    Google Scholar 

  48. Brunson, KW, Beattie, G, Nicolson, GL: Selection and altered tumour cell properties of brain-colonising metastatic melanoma. Nature 272: 543–545, 1978.

    Google Scholar 

  49. Raz, A, Hart, IR: Murine melanoma: a model for intracranial metastasis. Br J Cancer 42: 331–341, 1980.

    Google Scholar 

  50. Hart, IR, Talmadge, JE, Fidler, IJ: Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res 41: 1281–1287, 1981.

    Google Scholar 

  51. Kerbel, RS, Twiddy, RR, Robertson, DM: Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer 22: 583–594, 1978.

    Google Scholar 

  52. Fogel, M, Gorelik, E, Segal, S, Feldman, M: Differences in cell surface antigens of tumor metastases and those of the local tumor. J Natl Cancer Inst 62: 585–588, 1979.

    Google Scholar 

  53. Poste, G,Doll, J, Hart, IR, Fidler, IJ: In vitro selection of murine B16 melanoma variants with enhanced tissue invasive properties. Cancer Res 40: 1636–1644, 1980.

    Google Scholar 

  54. Fidler, IJ, Kripke, ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 197: 893–895, 1977.

    Google Scholar 

  55. Fidler, IJ, Kripke, ML: Tumor cell antigenicity host immunity and cancer metastasis. Cancer Immunol Immunother 7: 201–205, 1980.

    Google Scholar 

  56. Fidler, IJ, Gruys, E, Cifone, MA, Barnes, Z, Bucana, C: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67: 947–956, 1981.

    Google Scholar 

  57. Dexter, DL, Kowalski, HM, Blazar, BA, Fligiel, A, Vogel, R, Heppner, GH: Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38: 3174–3181, 1978.

    Google Scholar 

  58. Kripke, ML, Gruys, E, Fidler, IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 38: 2962–2967, 1978.

    Google Scholar 

  59. Suzuki, N, Williams, M, Hunter, NM, Withers, HR: Malignant properties and DNA content of daughter clones from a mouse fibrosarcoma: differentiation between malignant properties. Br J Cancer 42: 765–771, 1980.

    Google Scholar 

  60. Chambers, AF, Hill, RP, Ling, V: Tumor heterogeneity and stability of the metastatic phenotype of mouse KHT sarcoma cells. Cancer Res 41: 1368–1372, 1981.

    Google Scholar 

  61. Talmadge, JE, Starkey, JR, Stanford, DR: In vitro characteristics of metastatic variant subclones of restricted genetic origin. J Supramol Struct Cell Biochem 15: 139–151, 1981.

    Google Scholar 

  62. Enders, JF, Diamandopoulos, GT: A study of variation and progression in oncogenicity in an SV40-transformed hamster heart cell line and its clones. Proc Roy Soc B 171: 431–443, 1969.

    Google Scholar 

  63. Poste, G, Doll, J, Brown, AE, Tzeng, J, Zeidman, I: A comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors and individual lung tumors. Cancer Res 42: 2770–2778, 1982.

    Google Scholar 

  64. Mantovani, A, Giavazzi, R, Alessandri, G, Spreafico, F, Garattini, S: Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. Eur J Cancer 17: 71–76, 1981.

    Google Scholar 

  65. Fidler, IJ: Tumor heterogeneity and the biology of cancer metastasis. Cancer Res 38: 2651–2660, 1978.

    Google Scholar 

  66. Schirrmacher, V, Shantz, G, Clauer, K, Komitowski, D, Zimmermann, H-P, Lohmann-Matthes, M-L: Tumor metastases and cell-mediated immunity in a model system in DBA 2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer 23: 233–244, 1979.

    Google Scholar 

  67. Neri, A, Welch, D, Kawaguchi, T, Nicolson, GL: The development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68: 507–517, 1982.

    Google Scholar 

  68. Briles, EB, Kornfeld, S: Isolation and metastatic properties of detachment variants of B16 melanoma cells. J Natl Cancer Inst 60: 1217–1222, 1978.

    Google Scholar 

  69. Reading, CL, Belloi, PN, Nicolson, GL: Selection and in vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines. J Natl Cancer Inst 64: 1241–1249, 1980.

    Google Scholar 

  70. Tao, T, Matter, A, Vogel, K, Burger, MM: Liver-colonizing melanoma cells selected from B16 melanoma. Int J Cancer 23: 854–857, 1979.

    Google Scholar 

  71. Dennis, JW, Donaghue, TP, Carlow, DA, Kerbel, RS: Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants. Cancer Res 41: 4010–4019, 1981.

    Google Scholar 

  72. Hart, IR: The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 97: 587–600, 1979.

    Google Scholar 

  73. Fidler, IJ, Gersten, DM, Budmen, MB: Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res 36: 3160–3165, 1976.

    Google Scholar 

  74. Poste, G, Doll, J, Fidler, IJ: Interactions between clonal subpopulations affect the stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 78: 6226–6230, 1981.

    Google Scholar 

  75. Cifone, M, Fidler, IJ: Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78: 6949–6952, 1981.

    Google Scholar 

  76. Miller, BE, Miller, FR, Leith, J, Heppner, GH: Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res 40: 3977–3981, 1980.

    Google Scholar 

  77. Newcomb, EW, Silverstein, SC, Silagi, S: Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response. J Cell Physiol 95: 169–177, 1978.

    Google Scholar 

  78. Greene, HSN, Harvey, EK: The relationship between the dissemination of tumor cells and the distribution of metastases. Cancer Res 24: 799–806, 1964.

    Google Scholar 

  79. Ketcham, AS, Kinsey, DL, Wexler, H, Mantel, N: The development of spontaneous metastases after the removal of the primary tumor. Cancer 14: 875–886, 1961.

    Google Scholar 

  80. DeWys, WD: Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumorrelated systemic growth-retarding factors. Cancer Res 32: 374–381, 1972.

    Google Scholar 

  81. Sugarbaker, EV, Thornthwaite, J, Ketcham, AS: Inhibitory effect of a primary tumor on metastasis. In: Day, SB (ed) Cancer invasion and metastasis: biologic mechanisms and therapy. Raven Press, New York, 1977, pp 227–238.

    Google Scholar 

  82. Fidler, IJ, Hart, IR: The origin of metastatic heterogeneity in tumors. Eur J Cancer 17: 487–494, 1981.

    Google Scholar 

  83. Warren, BA: Origin and fate of blood-borne tumor emboli. Cancer Biol Rev 2: 95–169, 1981.

    Google Scholar 

  84. Fidler, IJ, Hart, IR: The development of biological diversity and metastatic potential in neoplasms. Biochim Biophys Acta 651: 37–50, 1981.

    Google Scholar 

  85. Fidler IJ, Poste G: The heterogeneity of metastatic properties in malignant tumor cells and regulation of the metastatic phenotype. In: Owens A (ed) Tumor cell heterogeneity. Academic Press, New York (in press).

  86. Sugarbaker, EV: Cancer metastasis: a product of tumor-host interactions. Current problems in cancer III: 3–59, 1979.

    Google Scholar 

  87. Poste G: Methods and models for studying tumor invasion. In: Hart IR, Liotta L (eds) Tumor invasion and metastasis. Martinus Nijhoff, The Hague (in press).

  88. Hart, IR, Fidler, IJ: An in vitro quantitative assay for tumor cell invasion. Cancer Res 38: 3218–3224, 1978.

    Google Scholar 

  89. Bosslet, K, Ruffmann, R, Altevogt, P, Schirrmacher, V: A rapid method for the isolation of metastasizing tumour cells from internal organs with the help of isopycnic density-gradient centrifugation in percoll. Br J Cancer 44: 356–362, 1981.

    Google Scholar 

  90. Mareel, MMK: Is invasiveness in vitro characteristic of malignant cells. Cell Biol Int Reports 3: 627–640, 1979.

    Google Scholar 

  91. Mareel, M, Bruyneel, E, DeBruyne, G, Dragonetti, G: Methods for morphological and biochemical analysis of invasion in vitro. In: DeBrabander, M, Mareel, M, De, Ridder, L (eds) Cell movement and neoplasia. Pergamon Press, Oxford, 1979, pp 87–95.

    Google Scholar 

  92. Folkman, J, Haudenschild, C: Angiogenesis in vitro: Nature 288: 551–556, 1980.

    Google Scholar 

  93. Trinkaus, JP: On the mechanism of metazoan cell movements In: Poste, G, Nicolson, GL (eds) The cell surface in animal embryogenesis and development cell surface reviews, Vol 1. Elsevier/North-Holland, Amsterdam, 1976, pp 225–329.

    Google Scholar 

  94. Maslow, DE: In vitro analysis of surface specificity in embryonic cells. In: Poste, G, Nicolson, GL (eds) The cell surface in animal embryogenesis and development, cell surface reviews, Vol 1. Elsevier/North-Holland, Amsterdam, 1976, pp 697–745.

    Google Scholar 

  95. Cassiman, JJ, Bernfield, MR: Transformation induced alterations in adhesion binding of preformed cell aggregates to cell layers. Exp Cell Res 103: 311–320, 1976.

    Google Scholar 

  96. Gershman, H, Drumm, J, Culp, L. Sorting out of normal and virus-transformed cells in cellular aggregates. J Cell Biol 68: 276–286, 1976.

    Google Scholar 

  97. MacDonald, HR, Howell, RL, McFarlane, DL: The multicellular spheroid as a model tumor allograft. Transplantation 25: 141–145, 1978.

    Google Scholar 

  98. Wiseman, LL: Contact inhibition and the movement of metal, glass and plastic beads within solid tissues. Experientia 34: 26–28, 1976.

    Google Scholar 

  99. Maslow, DE, Mayhew, E, Feldman, J: Differential inhibition of in vitro malignant cell assays by B16 melanoma variants. J Natl Cancer Inst 64: 635–638, 1980.

    Google Scholar 

  100. Poste G, Nicolson GL: In vitro systems for studying the interaction of metastatic tumour cells with endothelial cells and subendothelial basement membranes. In: Jaffe E (ed) Endothelial cells in culture. Raven Press, New York (in press).

  101. Harris, CC, Trump, BF, Stoner, GD (eds): Normal human tissue and cell culture: methods in cell biology, Vol 21. Academic Press, New York, 1980.

    Google Scholar 

  102. Liotta L, Garbisa S, Trygvason K: Biochemical mechanisms involved in tumor cell penetration of the basement membrane. In: Hart IR, Liotta LA (eds) Tumor invasion and metastasis. Martinus Nijhoff, The Hague (in press).

  103. Jones, PA, Scott-Burden, T: Activated macrophages digest the extracellular matrix proteins produced by cultured cells. Biochem Biophys Res Commun 86: 71–77, 1979.

    Google Scholar 

  104. Jones, PA, DeClerck, YA: Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res 40: 3222–3227, 1980.

    Google Scholar 

  105. Strauli, P, Barrett, AJ, Baici, A (eds): Proteinases and tumor invasion. Raven Press, New York, 1980.

    Google Scholar 

  106. Liotta, LA, Lee, C, Morakis, DJ: New method for preparing whole intact surfaces of human basement membrane for tumor invasion studies. Cancer Lett II: 141–152, 1980.

    Google Scholar 

  107. Gospodarowicz, D, Vlodavsky, I, Savion, N: The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells. J Supramol Struct 13: 339–372, 1980.

    Google Scholar 

  108. Witz, IP, Hanna, MGJr (eds): In situ expression of tumor immunity: contemporary topics in immunobiology, Vol 10. Plenum Press, New York, 1980.

    Google Scholar 

  109. Israel, L, Lagrange, PH, Salomon, JC (eds): Cancer immunology and parasite immunology. Inserm, Paris, 1981.

    Google Scholar 

  110. Fougereau, M, Dausset, J (eds): Immunology 80: Academic Press, New York, 1980.

    Google Scholar 

  111. Herberman, R (ed): Natural cell-mediated immunity against tumors. Academic Press, New York, 1980.

    Google Scholar 

  112. Sherbet, GV, Lakshmi, MS: Malignancy and prognosis evaluated by an embryonic system. Grading of breast tumours. Eur J Cancer 14: 415–420, 1978.

    Google Scholar 

  113. Poste, G, Flood, MK: Cells transformed by temperature-sensitive mutants of arian sarcoma virus cause tumors in vivo at permissive and nonpermissive temperatures. Cell 17: 789–900, 1979.

    Google Scholar 

  114. Warren, BA: Arrest extravasation of cancer cells with special reference to brain metastasis and the microinjury hypothesis. In: Weiss, L, Gilbert, HA, Posner, J (eds) Brain metastasis. GK Hall, Boston, 1980, pp 81–89.

    Google Scholar 

  115. Glaves, D, Weiss, L: Early arrest of circulating tumor cells in tumor bearing mice. In: Day, SB (ed) Cancer invasion and metastasis: biologic mechanisms and therapy. Raven Press, New York, 1977, pp 175–184.

    Google Scholar 

  116. Zeidman, I: The fate of circulating tumor cells. I. Passage through capillaries. Cancer Res 21: 38–39, 1961.

    Google Scholar 

  117. Weiss, L: Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer 25: 385–392, 1980.

    Google Scholar 

  118. Erickson, CA: The deformability of BHK cells and polyoma virus-transformed BHK cells in relation to locomotory behaviour. J Cell Sci 44: 187–200, 1980.

    Google Scholar 

  119. Raz, A, Hanna, N, Fidler, IJ: In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst 66: 183–189, 1981.

    Google Scholar 

  120. Sato, H, Suzuki, M: Deformability and viability of tumor cells by transcapillary passage, with reference to organ affinity of metastasis in cancer. In: Weiss, L (ed) Fundamental aspects of metastases. Elsevier/North-Holland, Amsterdam, 1976, pp 311–318.

    Google Scholar 

  121. Lessin, LS, Kurantsin-Mills, J, Weems, HB: Deformability of normal and sickle erythrocytes in a pressure-flow filtration system. Blood Cells 3: 241–262, 1977.

    Google Scholar 

  122. Weiss, L (ed): Cell deformability: some general considerations. In: Weiss, L (ed) Fundamental aspects of metastasis. Elsevier/North-Holland, Amsterdam, 1976, pp 305–310.

    Google Scholar 

  123. Hart, IR, Talmadge, JE, Fidler, IJ: Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ specific growth. Cancer Res 41: 1281–1287, 1981.

    Google Scholar 

  124. Evans, EA, Waugh, RE: Mechano-chemical study of red cell membrane structure in situ. In: Cokelet, GR, Meiselman, HJ, Brooks, DE (eds) Erythrocyte mechanics and blood flow, Vol 13. AR Liss, New York, 1980, pp 31–56.

    Google Scholar 

  125. Greig, RG, Brooks, DE: Shear-induced concanavalin A agglutination of human erythrocytes. Nature 282: 738–739, 1979.

    Google Scholar 

  126. Van, Rooijen, N: Labeling of lymphocytes with various radioisotopes for in vivo tracer studies: a review. J Immunol Methods 15: 267–277, 1977.

    Google Scholar 

  127. Marcum, JM, McGill, M, Bastida, E, Ordinas, A, Jamieson, GA: The interaction of platelets, tumor cells, and vascular subendothelium. J Lab Clin Med 96: 1046–1053, 1980.

    Google Scholar 

  128. Kramer, RH, Nicolson, GL: Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc Natl Acad Sci USA 76: 5704–5708, 1979.

    Google Scholar 

  129. Kramer, RH, Gonzalez, R, Nicolson, GL: Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 26: 639–645, 1980.

    Google Scholar 

  130. Jones, PA, Neustein, HB, Gonzales, F, Bogenmann, E: Invasion of an artificial blood vessel wall by human fibrosarcoma cells. Cancer Res 41: 4613–4620, 1981.

    Google Scholar 

  131. Ludatscher, RM, Luse, SA, Suntzeff, V: An electron microscope study of pulmonary tumor emboli from transplanted Morris hepatoma 5123. Cancer Res 27: 1939–1946, 1967.

    Google Scholar 

  132. Wood, S: Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch Pathol 66: 550–568, 1958.

    Google Scholar 

  133. Fidler, IJ, Gersten, DM, Hart, IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149–250, 1978.

    Google Scholar 

  134. Wang, BS, McLouglin, GA, Richie, JP, Mannick, JA: Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res 40: 288–292, 1980.

    Google Scholar 

  135. Nicolson, GL, Birdwell, CR, Brunson, KW, Robbins, JC, Beattie, G, Fidler, IJ: Cell interactions in the metastatic process. Some cell surface properties associated with successful blood-borne tumor spread. In: Lash, JW, Burger, MM (eds) Cell and tissue intaractions. Raven, New York, 1977, pp 225–241.

    Google Scholar 

  136. Talmadge, JE, Starkey, JR, Stanford, DR: In vitro characteristics of metastatic variant subclones of restricted genetic origin. J Supramol Struct 15: 139–151, 1981.

    Google Scholar 

  137. Kramer RH, Vogel KG, Nicolson GL: Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem 257: 2678–2686.

  138. Irimura T, Nicolson GL: The role of glycocongugates in metastatic melanoma blood-borne arrest and cell surface properties. J Supramol Struct Cell Biochem (in press).

  139. Poste, G, Nicolson, GL: Arrest and metastasis of bloodborne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399–403, 1980.

    Google Scholar 

  140. Black, PH: Shedding from all the cell surface of normal cancer cells. Adv Cancer Res 32: 75–199, 1980.

    Google Scholar 

  141. Poste, G, Lyon, NC, Macander, P, Porter, CW, Reeve, P, Bachmeyer, H: Liposome-mediated transfer of integral membrane glycoproteins into the plasma membrane of cultured cells. Exp Cell Res 129: 393–408, 1980.

    Google Scholar 

  142. Macarak, EJ, Howard, BV, Kirby, E, Kefalides, NA: Biosynthesis of basement membrane collagen by cultured endothelial cells. Front Matrix Biol 7: 27–36, 1979.

    Google Scholar 

  143. Maciag T, Kadish J, Stemerman MB, Weinstein R: The organizational behavior of human umbilical vein endothelial cells. J Cell Biol (in press).

  144. Irimura, T, Gonzalez, R, Nicolson, GL: Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Cancer Res 41: 3411–3418, 1981.

    Google Scholar 

  145. Ewing, J (ed): Neoplastic diseases. WB Saunders Co., Philadelphia, 1928.

    Google Scholar 

  146. Weiss, L, Haydock, K, Pickren, JW, Lane, WW: Organ vascularity and metastatic frequency. Am J Pathol 101: 101–114, 1980.

    Google Scholar 

  147. Fidler, IJ: Metastasis. Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 45: 775–782, 1970.

    Google Scholar 

  148. Fidler, IJ, Gersten, DM, Riggs, CW: Relationship of host immune status to tumor cell arrest, distribution and survival in experimental metastasis. Cancer 40: 46–55, 1977.

    Google Scholar 

  149. Fisher, B, Fisher, ER: The organ distribution of disseminated 51Cr-labeled tumor cells. Cancer Res 27: 412–420, 1967.

    Google Scholar 

  150. Paget, S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571–573, 1889.

    Google Scholar 

  151. Hart, IR, Fidler, IJ: The role of organ selectivity in the determination of metastatic patterns of the B16 melanoma. Cancer Res 40: 2281–2287, 1980.

    Google Scholar 

  152. Hart, IR, Fidler, IJ: Cancer invasion and metastasis. Q Rev Biol 55: 121–142, 1980.

    Google Scholar 

  153. Raz, A, Hanna, N, Fidler, IJ: In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst 66: 183–194, 1981.

    Google Scholar 

  154. Nicolson, GL, Custead, SE: Tumor metastasis is not due to adaptation of cells to a new organ environment. Science 215: 176–178, 1982.

    Google Scholar 

  155. Brunson KW, Nicolson GL: Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst 61: 1499–1503.

  156. Talmadge, JE, Key, ME, Hart, IR: Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. Cancer Res 41: 1271–1280, 1981.

    Google Scholar 

  157. Nicolson, GL, Winkelhake, JL: Organ specificity of bloodborne tumor metastasis determined by cell adhesion? Nature 255: 230–232, 1975.

    Google Scholar 

  158. Phondke, GP, Madyastha, KR, Madyastha, PR, Barth, RF: Relationship between concanavalin A-induced agglutinability of murine leukemia cells and their propensity to form heterotypic aggregates with syngeneic lymphoid cells. J Natl Cancer Inst 66: 643–647, 1981.

    Google Scholar 

  159. Schirrmacher, V, Cheinsing-PoPov, R, Arheiter, H: Hepatocyte-tumour cell interaction in vivo. I. Conditions for rosette formation and inhibition by anti-H2 antibody. J Exp Med 151: 984–989, 1980.

    Google Scholar 

  160. Nicolson GL: Personal communication.

  161. Yakushiji, K, Sakai, A, Oki, S, Butt, KM: Localization of organ-specific alloantigens in the kidney. In: Monaco, AP, Wood, ML, Rapoport, FT (eds) Transplantation today. Grune & Stratton, New York, 1981, pp 1187–1188.

    Google Scholar 

  162. Lalezari, P: Organ-specific and systemic alloantigens: interrelationships and biologic implications. Transplant Proc 12: 12–21, 1980.

    Google Scholar 

  163. Cerilli, J, Brasile, L: Endothelial cell alloantigens. Transplant Proc 12: Suppl 1, 37–42, 1980.

    Google Scholar 

  164. Weiss, L, Gilbert, HA, Ballon, SC (eds): Lymphatic system metastasis. GK Hall, Boston 1980.

    Google Scholar 

  165. Sato, H: Studies on the role of cancer chemotherapy for prevention of lymph-node metastasis. Cancer Chemother Rep 13: 33–40, 1961.

    Google Scholar 

  166. Van, Putten, LM, Kram, LKJ, Vandiere, HH, Smink, T, Fuzy, M: Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection. Int J Cancer 15: 588–595, 1975.

    Google Scholar 

  167. Franchi, G, Reyers-Degli Innocenti, I, Rosso, R, Garattini, S: Lymph node metastases after intratibial transplantation of tumors. Int J Cancer 3: 765–770, 1968.

    Google Scholar 

  168. Zeidman, I: Experimental studies on the spread of cancer in the lymphatic system. IV. Retrograde spread. Cancer Res 19: 1114–1117, 1959.

    Google Scholar 

  169. Fisher, B, Fisher, ER: Barrier functions of lymph node to tumor cells and erythrocytes. Cancer 20: 1907–1919, 1967.

    Google Scholar 

  170. Herman, PG, Kim, CS, Sousa, MABD, Mellins, HZ: Microcirculation of the lymph node with metastases. Am J Pathol 85: 333–348, 1976.

    Google Scholar 

  171. Carter, RL: Lymphoreticular reactions and the metastatic process. In: Baldwin, RW (ed) Secondary spread of cancer. Academic Press, London, 1978, pp 116–135.

    Google Scholar 

  172. Hanna, MG, Peters, LC: Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery. Cancer 42: 2613–2625, 1978.

    Google Scholar 

  173. Carr, I, McGinty, F, Norris, P: The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumor. J Pathol 118: 91–99, 1976.

    Google Scholar 

  174. Carr, J, Carr, I, Dreher, B, Franks, CR: Lymphatic metastasis of tumours: persistent transport of cells. Experentia 35: 825–828, 1979.

    Google Scholar 

  175. Pollard, M, Luckert, PH: Transplantable metastasizing prostate adenocarcinoma in rats. J Natl Cancer Inst 54: 634–649, 1975.

    Google Scholar 

  176. Bogden, AE, Esber, HJ, Taylor, DJ, Gray, JH: Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma. Cancer Res 34: 1627–1631, 1974.

    Google Scholar 

  177. Kim, U: Metastasizing mammary carcinomas in rats: induction and study of their immunogenicity. Science 167: 72–74, 1970.

    Google Scholar 

  178. Kurokawa, Y: Experiments on lymph node metastasis by intralymphatic inoculation of rat ascites tumour cells, with special reference to lodgement, passage and growth of tumor cells in lymph nodes. Gann 61: 461–471, 1970.

    Google Scholar 

  179. Becker, FF: Patterns of spontaneous metastasis of transplantable hepatocellular carcinomas. Cancer Res 38: 163–167, 1978.

    Google Scholar 

  180. Kodama, T: Pathology of immunologic regression of tumor metastases in the lymph nodes. Gann 20: 83–91, 1977.

    Google Scholar 

  181. Finlay-Jones, JJ, Bartholomaeus, WN, Fimmel, PJ, Keast, D, Stanley, NF: Biologic and immunologic studies on a murine model of regional lymph node metastasis. J Natl Cancer Inst 64: 1363–1372, 1980.

    Google Scholar 

  182. Barna, B, Deodhar, S: The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors. Cancer Res 35: 920–926, 1975.

    Google Scholar 

  183. Hewitt, HB, Blake, E: Quantitative studies of translymphnodal passage of tumour cells naturally disseminated from a non-immunogenic murine squamous carcinoma. Br J Cancer 31: 25–35, 1975.

    Google Scholar 

  184. Van de, Velde, CJ, Meyer, CJ, Cornellsse, CJ, Van de, Velde, EA, Van, Putten, LM, Swaveling, A: A morphometric analysis of lymph-node responses to tumors of different immunogenicity. Cancer Res 38: 661–667, 1978.

    Google Scholar 

  185. Tsukagoshi, S, Sakurai, Y: Cancer chemotherapy screening with experimental tumors which metastasize to lymph nodes. Cancer Chemother Rep 54: 311–318, 1970.

    Google Scholar 

  186. Sheffler, BA, Repman, MA, Schengrund, CL: Development of a neonatal and metastatic murine neuroblastoma model. Cancer Res 39: 711–713, 1979.

    Google Scholar 

  187. Hagmar, B, Ryd, W: Metastasis spread from syngeneic murine tumours. Acta Pathol Microbiol Scand 86: Sect A, 231–239, 1978.

    Google Scholar 

  188. Kreider, JW, Bartlett, GL, Purnell, DM, Webb, S: Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with corynebacterium parvum. Cancer Res 38: 4522–4526, 1978.

    Google Scholar 

  189. Carr, I, Carr, J: Experimental lymphatic invasion and metastasis. In: Weiss, L, Gilbert, HA, Ballon, SC (eds) Lymphatic system metastasis. GK Hall, Boston, 1980, pp 41–73.

    Google Scholar 

  190. Schabel, FMJr: Laboratory methods for the detection and development of clinically useful anticancer drugs. In: Burchenal, JH, Oettgen, HF (eds) Cancer: achievements challenges and prospects for the 1980's, Vol 2. Grune & Stratton, New York, 1981, pp 11–32.

    Google Scholar 

  191. Fidler, IJ, White, RJ (eds): Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982.

    Google Scholar 

  192. Salmon, SE (ed): Cloning of human tumor stem cells. AR Liss, New York, 1980.

    Google Scholar 

  193. Van, Hoff, DD, Weisenthal, L: In vitro methods to predict for patient response to chemotherapy. Adv Pharmacol Chemother 17: 133–156, 1980.

    Google Scholar 

  194. Hamburger, AW: Use of in vitro tests in predictive cancer chemotherapy. J Natl Cancer Inst 66: 981–988, 1981.

    Google Scholar 

  195. Momparler, RL: In vitro systems for evaluation of combination chemotherapy. Pharm Therap 8: 21–35, 1981.

    Google Scholar 

  196. Venditti, JM: The model's dilemma. In: Fidler, IJ, White, RJ (eds) Design of models for testing cancer therapeutic agents. Van Nostrand, New York, 1982, pp 80–94.

    Google Scholar 

  197. Buick, RN: In vitro clonogenicity of primary human tumor cells: quantitation and relationship to tumor stem cells. In: Salmon, SE (ed) Cloning of human tumor stem cells. AR Liss, New York, 1980, pp 15–22.

    Google Scholar 

  198. Poste, G, Fidler, IJ: Stimulation of macrophage-mediated destruction of lung metastases by administration of immunomodulators encapsulated in liposomes. In: Nicolau, C, Paraf, A (eds) Liposomes, drugs and immunocompetent cell functions. Academic Press, London, 1981, pp. 147–161.

    Google Scholar 

  199. Frei, EIII: Models and the clinical dilemma. In: Fidler, IJ, White, RJ (eds) Design of models for testing cancer chemotherapeutic agents. Van Nostrand, New York, 1982, pp 248–259.

    Google Scholar 

  200. Takahashi, S, Yoichi, K, Nakatani, I, Inui, S, Kojima, K, Shiratori, T: Conversion of a poorly differentiated human adenocarcinoma to ascites form with invasion and metastasis in nude mice. J Natl Cancer Inst 60: 925–927, 1978.

    Google Scholar 

  201. Brunson, KW, Nicolson, GL: Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst 61: 1499–1508, 1978.

    Google Scholar 

  202. Nicolson, GL, Reading, CL, Brunson, KW: Blood-borne tumor metastasis: Some properties of selected tumor cell variants of differing malignancies. In: Crispen, RG (ed) Tumor progression. Elsevier/North-Holland, Amsterdam, 1980, pp 31–42.

    Google Scholar 

  203. Yogeeswaran, G, Stein, BS, Sebastian, H: Characterization of tumorigenic and metastatic properties of murine sarcoma virus-transformed non-producer BALB/3T3 cell lines. J Natl Cancer Inst 64: 951–957, 1980.

    Google Scholar 

  204. Brunson, KW, Nicolson, GL: Selection of malignant melanoma variant cell lines for ovary colonization. J Supramol Struct 11: 517–528, 1979.

    Google Scholar 

  205. Hammond, WG, Rolley, RT: Retained regional lymph nodes: effect on metastases and recurrence after tumor removal. Cancer 25: 368–372, 1970.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Smith Kline and French Laboratories, 1500 Spring Garden Street, 19101, Philadelphia, Pennsylvania, USA

    George Poste

  2. Department of Pathology and Laboratory Medicine, University of Pennsylvania, 19104, Philadelphia, Pennsylvania, USA

    George Poste

Authors
  1. George Poste
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poste, G. Experimental systems for analysis of the malignant phenotype. Cancer Metast Rev 1, 141–199 (1982). https://doi.org/10.1007/BF00048224

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00048224

Keywords

Search

Navigation